Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2

The retrospective data give evidence that there is no difference in outcome for the use of ivMP + PE over ivMP + IVIG or vice versa in the treatment of encephalitis caused by antibodies against NMDAR, LGI1 or CASPR2. Furthermore, the specific method of plasma exchange, whether plasmapheresis or immunoadsorption, did not affect the mRS at discharge.

Authors

Institutions

Publication Details

Journal
Journal of Neurology
Published
2025-03-25
DOI
https://doi.org/10.1007/s00415-025-13032-0
Citations
8
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
11.11

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2

Jan Lewerenz, Marie Madlener, Martin Lesser, Makbule Şenel et al.
8 citations
Journal of Neurology
Autoimmune Neurological Disorders and Treatments
11.11
article

Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2

Jan Lewerenz, Marie Madlener, Martin Lesser, Makbule Şenel, Hagen B. Huttner, Manuel Alexander Friese, Michael Nagel, Tania Kümpfel, Simone C. Tauber, Frank Leypoldt, Harald Prüß, Sven Guenther Meuth, Franziska Thaler, Kurt‐Wolfram Sühs, Kevin M. Rostasy, Michael P. Malter, Kathrin Doppler, Thorsten Bartsch, Nico Melzer, Florian Then Bergh, Carsten Finke, Jonathan Wickel, Christian Geis, Orhan Aktas, Andréas Moser, Frank Hoffmann, Andrea Kraft, Klaus-Peter Wandinger, Martin Stangel, Dominica Hudasch, Joyce Christin Rittel
article en
8 citations

Abstract

The retrospective data give evidence that there is no difference in outcome for the use of ivMP + PE over ivMP + IVIG or vice versa in the treatment of encephalitis caused by antibodies against NMDAR, LGI1 or CASPR2. Furthermore, the specific method of plasma exchange, whether plasmapheresis or immunoadsorption, did not affect the mRS at discharge.

Journal of NeurologyVol. 272(4)
Novartis (Switzerland) (CH), Witten/Herdecke University (DE), Universität Hamburg (DE), University of Cologne (DE), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Universität Ulm (DE), Justus-Liebig-Universität Gießen (DE), German Center for Neurodegenerative Diseases (DE), Christian-Albrechts-Universität zu Kiel (DE), Medizinische Hochschule Hannover (DE), Düsseldorf University Hospital (DE), University Hospital Münster (DE), University Medical Center Hamburg-Eppendorf (DE), University Hospital Schleswig-Holstein (DE), Universitätsklinikum Aachen (DE), Universitätsklinikum Würzburg (DE), Jena University Hospital (DE), Klinikum Osnabrück (DE), Martha-Maria Hospital (DE), University Hospital Cologne (DE), University Hospital Carl Gustav Carus (DE), Heinrich Heine University Düsseldorf (DE), Technische Universität Dresden (DE), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE), RWTH Aachen University (DE), Leipzig University (DE), University of Lübeck (DE)
Bundesministerium für Bildung und Forschung
Good health and well-being
Openalex Percentile: Top 1%
Autoimmune Neurological Disorders and Treatments
11.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.